CA 19-9 – Private Blood Tests

This CA 19-9 blood test is tested to help differentiate between pancreatic cancer and bile ducts. This test helps to monitor the response to pancreatic cancer treatment and to look out for recurrence. This confidential blood assay for CA 19-9 is offered at all of the thirty two private clinics across England, Scotland
This CA 19-9 blood test is tested to help differentiate between pancreatic cancer and bile ducts. This test helps to monitor the response to pancreatic cancer treatment and to look out for recurrence. This confidential blood assay for CA 19-9 is offered at all of the thirty two private clinics across England, Scotland and Wales. Included in every single test for CA 19-9 are a Doctors Referral, all Phlebotomy fees (your blood taken at a Private Hospital), all laboratory fees and includes our GP comments.

Frontiers The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704 - Advances in Radiation Oncology

Tumor Marker Test (CA 19-9 -GIT, Pancreas)

Elecsys CA 19.9

CA 19-9 Blood Test —

Tests to Diagnose Pancreatic Cancer and What You Can Expect

Tumor Marker Screening For Men & Women At IDC

CA 19-9 level in different T stages, grades, depth of invasion, and in

JCM, Free Full-Text